title: Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine.
abstract: An 8-week, double-blind, flexible-dose trial comparing low doses of clomipramine (mean=50 mg) with moderate doses of imipramine (mean=113.8 mg and propanteline (active placebo), was carried out in 60 out-patients with panic disorder with or without agoraphobia. Efficacy evaluation included global, anxiety and depression rating scales, and the determination of rates of relapse over up to 10 weeks of single-blind placebo follow-up. Both tricyclics were significantly more effective than propanteline, but clomipramine tended to act faster and more consistently than imipramine on most measures. Given the degree of blindness achieved and the significantly lower doses of clomipramine, this seems a better reference drug than imipramine for clinical trials in panic/agoraphobia.
authors.affiliation: LIM-23 Departamento de Psiquiatria, Faculdade de Medicina.
authors.forename: V
authors.initials: V
authors.lastname: Gentil
authors.forename: F
authors.initials: F
authors.lastname: Lotufo-Neto
authors.forename: L
authors.initials: L
authors.lastname: Andrade
authors.forename: T
authors.initials: T
authors.lastname: Cordás
authors.forename: M
authors.initials: M
authors.lastname: Bernik
authors.forename: R
authors.initials: R
authors.lastname: Ramos
authors.forename: L
authors.initials: L
authors.lastname: Maciel
authors.forename: E
authors.initials: E
authors.lastname: Miyakawa
authors.forename: C
authors.initials: C
authors.lastname: Gorenstein